文献速递临床试验与 GCP

远端胰腺切除术后腹腔引流与不引流对比:一项随机对照试验的研究方案

Abdominal drainage versus no drainage after distal pancreatectomy: study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2019-06-07

PANDRA II 试验为单中心随机对照非劣效性试验,比较远端胰腺切除术后预防性腹腔引流与不引流的临床结局。主要终点为90天内全部术后并发症的综合并发症指数(CCI),计划分析252例患者,以检验不引流在CCI上非劣效于引流(δ 7.5分)。

要点

  • PANDRA II 试验比较远端胰腺切除术后预防性腹腔引流与不引流的临床结局。
  • 主要终点为90天内全部术后并发症的综合并发症指数(CCI)。
  • 计划分析252例患者,非劣效界值δ 7.5分,单侧显著性水平2.5%,把握度80%。

核心结论

  • PANDRA II 试验结果将有助于评估开放或微创远端胰腺切除术后省略预防性腹腔引流对并发症发生率的影响。

研究设计与样本

  • PANDRA II 试验为单中心、随机对照、非劣效性试验,设两个平行研究组。
  • 对照组在胰腺切除缘放置至少一根被动腹腔引流管,试验组不放置引流管。
  • 计划分析252例患者,以单侧t检验检验不引流在CCI上非劣效于引流(δ 7.5分),单侧显著性水平2.5%,把握度80%。

主要发现

  • PANDRA 试验显示,胰头切除术后省略引流在术后再干预方面非劣效于腹腔引流,在临床相关胰瘘率和瘘相关并发症方面更优。

关键数值与推荐

  • 主要终点为测量90天内全部术后并发症的综合并发症指数(CCI)。
  • 次要终点包括院内死亡率和发病率,含术后胰瘘、乳糜漏、胰腺切除术后出血、胃排空延迟、再干预和再手术、手术部位感染及腹壁筋膜裂开的发生率。
  • 此外评估住院时间、重症监护病房停留时间及出院后(至术后第90天)再入院率。
  • 非劣效界值δ为7.5分,单侧显著性水平2.5%,把握度80%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The placement of prophylactic intra-abdominal drains has been common practice in abdominal operations including pancreatic surgery. The PANDRA trial showed that the omission of drains following pancreatic head resection was non-inferior to intra-abdominal drainage in terms of postoperative reinterventions and superior in terms of clinically relevant pancreatic fistula rate and fistula-associated complications. The aim of the present PANDRA II trial is to evaluate the clinical outcome with versus without prophylactic drain placement after distal pancreatectomy. METHODS: The PANDRA II trial is a mono-center, randomized controlled, non-inferiority trial with two parallel study groups. In the control group at least one passive intra-abdominal drain is placed at the pancreatic resection margin. In the experimental group no drains are placed. The primary endpoint of this trial will be the Comprehensive Complication Index (CCI) measuring all postoperative complications within 90 days. Secondary endpoints are in-hospital mortality and morbidity, including the rates of postoperative pancreatic fistula, chyle leak, postpancreatectomy hemorrhage, delayed gastric emptying, reinterventions and reoperations, surgical site infection, and abdominal fascia dehiscence. Moreover, length of hospital stay, duration of intensive care unit stay, and the rate of readmission after discharge from hospital (up to day 90 after surgery) are assessed. We will need to analyze 252 patients to test the hypothesis that no drainage is non-inferior to drain placement in terms of the CCI (δ 7.5 points) in a one-sided t test with a one-sided level of significance of 2.5% and a power of 80%. DISCUSSION: The results of the PANDRA II trial will help to evaluate the effect of an omission of prophylactic intraperitoneal drainage on the rate of complications after open or minimally invasive distal pancreatectomy. TRIAL REGISTRATION: German Clinical Trials Register (DRKS), DRKS00013763 . Registered on 6 March 2018.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Kaiser J, Niesen W, Probst P, et al. Abdominal drainage versus no drainage after distal pancreatectomy: study protocol for a randomized controlled trial. Trials. 2019. PMID: 31174583. doi:10.1186/s13063-019-3442-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。